Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Rheumatic Diseases
Open-data reference.
12 US clinical trials · 4 currently recruiting
Active & Recent Trials
Observational Pharmaco-Epidemiology Research & Analysis
Epividian
NCT03813862
Studies of the Natural History of Rheumatic Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NCT00024479
Rheumatology Patient Registry and Biorepository
Yale University
NCT04402086
A Study of SPY072 in Rheumatic Disease
Spyre Therapeutics
NCT07148414
Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications
VA Office of Research and Development
NCT02694185
The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)
Oregon Health and Science University
NCT05543642
SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization
CrannMed
NCT06550024
Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases
Northwestern University
NCT05822219
Impact of Different Exercise Programs on Knee OA
Shirley Ryan AbilityLab
NCT05844124
Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia
Children's Hospital Medical Center, Cincinnati
NCT03268421
Study Comparing Marathon Polyethylene and Enduron Polyethylene Acetabular Liners Used in Total Hip Arthroplasty
Anderson Orthopaedic Research Institute
NCT01121146
Marathon and Enduron Polyethylene at Long-Term Follow-up
Anderson Orthopaedic Research Institute
NCT02508428
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Rheumatic Diseases Trial Landscape
ClinicalTrials.gov lists 12 US studies indexed under Rheumatic Diseases, and 4 of those are currently open to recruitment — roughly 33% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Rheumatic Diseases shows 1 late-stage studies (Phase 3 and Phase 4 combined) alongside 1 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Rheumatic Diseases is led by Anderson Orthopaedic Research Institute with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 12 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Rheumatic Diseases?
PlainTrial tracks 12 US clinical trials for Rheumatic Diseases, of which 4 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Rheumatic Diseases?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.